News

Recent News

Reflections on IAS 2019 from a Differentiated Service Delivery Perspective by Dr. Ingrid Bassett

September 30, 2019

Dr. Ingrid Bassett, HU CFAR Developmental and Mentoring Core Director, was a plenary speaker at IAS 2019 in Mexico City. 

"The 10th IAS Conference on HIV Science (IAS 2019) was notable to me for two reasons. Firstly, it was a shift away from the 90-90-90 national targets to a more nuanced awareness of which populations are not being reached with existing HIV services. Secondly, differentiated service delivery (DSD) models were applied not...

Read more about Reflections on IAS 2019 from a Differentiated Service Delivery Perspective by Dr. Ingrid Bassett

Training Opportunity: Apply for Inter-CFAR Implementation Science Fellowship for Early Stage Investigators

September 25, 2019

Inter-CFAR Fellowship Program in Implementation Science for Early-Stage HIV Investigators

 

Collaborating CFARs: Johns Hopkins University, University of North Carolina, University of California San Francisco/GIVI, Emory University, Third Coast CFAR – Northwestern, Harvard University, University of Washington,...

Read more about Training Opportunity: Apply for Inter-CFAR Implementation Science Fellowship for Early Stage Investigators

Apply Now: HU CFAR RFPs for awards beginning February 2020

August 21, 2019

The HU CFAR is pleased to announce a general and special emphasis RFP for the latest cycle of Developmental Core awards to begin February 2020.  General awards may request up to $60k in direct costs.  Special emphasis awards around the topic of Community Engaged Research to Address HIV Prevention, Care and Treatment Challenges may request up to $100k in direct costs.

Take advantage of an expert pre-review to strenghten your application.  Pre-review and consultation is also available from a number of HU CFAR faculty from...

Read more about Apply Now: HU CFAR RFPs for awards beginning February 2020

NEW FOA from FIC; NIDA; NIMH; NCI: "Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries" (R21 Clinical Trial Optional)

August 7, 2019

FOA was recently published on Stigma, “Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional)” https://grants.nih.gov/grants/guide/pa-files/PAR-19-326.html

... Read more about NEW FOA from FIC; NIDA; NIMH; NCI: "Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries" (R21 Clinical Trial Optional)
NIH logo

NIH Funding Opportunity Announcement (FOA)

June 10, 2019

Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support basic science research, from early exploratory studies to therapeutic discovery and development, in novel biologically active viral and/or host RNAs involved in virology (including HIV biology) and immune regulation.

...

Read more about NIH Funding Opportunity Announcement (FOA)
More